iAnthus Capital Holdings, Inc.

C$0.01As of Sun 8 Nov 2026, 12:00 UTC
CSE:IANHealthcare
Country Canada
PE (Fwd) •••
TSR 10Y CAGR (47.69%)
Div yield —
ROE —
Drug Manufacturers (Specialty & Generic)
Beta (5Y) (0.54)
PE TTM —
TSR TTM (50.00%)
Mkt cap C$34.87M
ROIC (5.33%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$0.0064
28.36%
(97.10%)
Hold 0|10|6|10|3
4Q25
1Q26
2Q26
3Q26
Earnings per share$
—
—
—
—
16.11%
12.49%
1.68%
(8.37%)
Revenue$M
1.852
1.832
1.939
1.913
15.54%
10.31%
10.79%
6.13%
Peers (US$24.68M)
Cap (US$)
PE
Capital
TTM
5Y
10Y
Leveragex
1.328
0.077
0.075
EBIT/Intx
0.540
0.102
0.102
Own earn%
336.30
(373.67)
(276.73)
Sh yield%
33.79
23.27
21.83
Owners
Insiders/Inst%
12.80
65.67
Short interest%
5.09
SBC / revenue%
5.44
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
21
Op margin range%
6–12
$1 testx
—
Incr. ROIC%
3